Skip to main content

Assessing a Novel Target for the Treatment of Major Depressive Disorder


An estimated one in three patients diagnosed with major depressive disorder does not respond to existing therapeutics. But James Murrough, MD, PhD, has identified a novel therapeutic target that, based on his studies, has the potential to change that paradigm and the lives of millions of patients worldwide.

Learn More